Skip to main content

Table 1 Association between LBCS expression and clinicopathological features of prostate cancer from Cohort 1

From: A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer

Characteristics Cases (%) χ 2 P-value
Total Cohort 1 Patients (N) 130   
Patients with complete clinical and follow up information (N) 130   
LBCS expression Low High   
Age (Year)
 ≤70 30 (23) 39 (30) 2.502 0.114
 >70 35 (27) 26 (20)
Gleason Score
 6–7 27 (21) 50 (38) 16.851 0.000*
 8–10 38 (29) 15 (12)
Tumor stage
 T1–2 27 (21) 52 (40) 20.166 0.000*
 T3–4 38 (29) 13 (10)
Lymphnodes status N
 Negative 50 (38) 58 (45) 3.502 0.061
 Positive 15 (12) 7 (5)
Distant Metastasis M
 M0 55 (24) 59 (33) 1.140 0.286
 M1 10 (25) 6 (18)
  1. *P<0.05 is considered significant
  2. Median H-Score of LBCS was used as cut-off value for analysis